InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
T+90 hit rate
50%
T+90 mean return
+4.7%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Grygiel Nancy A., Directeur. Officer active across 1 company, notably AMGEN INC. Aggregated, 40 filings have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €2.1m. History available since 30 April 2021. The latest transaction was disclosed on 4 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations40 total
126 shares@ US$329.820.0000% mcap0.8% of flowCommon StockSEC:0000318154-26-000064:0
116 shares@ US$329.820.0000% mcap0.7% of flowCommon StockSEC:0000318154-26-000064:1
1,237 shares@ US$323.72720.0002% mcap7.3% of flowCommon StockSEC:0000318154-26-000064:2
591 shares0Common StockSEC:0001127602-25-013783:0
118 shares@ US$283.780.6% of flowCommon StockSEC:0001127602-25-013530:0
111 shares@ US$283.780.6% of flowCommon StockSEC:0001127602-25-013530:1
113 shares@ US$288.560.6% of flowCommon StockSEC:0001127602-25-013283:0
524 shares@ US$313.713.2% of flowCommon StockSEC:0001127602-25-010057:0
1,503 shares0Common StockSEC:0001127602-25-008425:0
1,589 shares@ US$304.47319.9% of flowCommon StockSEC:0001127602-25-003500:0
1,565 shares@ US$333.2810.3% of flowCommon StockSEC:0001127602-24-021277:0
499 shares0Common StockSEC:0001127602-24-014855:0
82 shares@ US$311.290.5% of flowCommon StockSEC:0001127602-24-014509:0
114 shares@ US$277.370.6% of flowCommon StockSEC:0001127602-24-014194:0
2,117 shares@ US$313.085313.2% of flowCommon StockSEC:0001127602-24-014198:0
106 shares@ US$276.380.6% of flowCommon StockSEC:0001127602-24-013815:0
703 shares@ US$268.873.7% of flowCommon StockSEC:0001127602-24-010854:0
1,954 shares0Common StockSEC:0001127602-24-009244:0
2,096 shares@ US$273.032311.2% of flowCommon StockSEC:0001127602-23-028779:0
249 shares@ US$269.861.3% of flowCommon StockSEC:0001127602-23-026976:0
1,129 shares@ US$236.375.2% of flowCommon StockSEC:0001127602-23-021594:0
54 shares@ US$231.890.2% of flowCommon StockSEC:0001127602-23-015047:0
635 shares0Common StockSEC:0001127602-23-014614:0
73 shares@ US$239.740.3% of flowCommon StockSEC:0001127602-23-014153:0
339 shares@ US$234.571.6% of flowCommon StockSEC:0001127602-23-010917:0
25 of 40 declarations
About Grygiel Nancy A.
Nancy A. Grygiel is Senior Vice President and Chief Commercial Officer at Amgen Inc, a biopharmaceutical company. She plays a key role in business development and market strategy, contributing to the company's growth and impact in the healthcare sector.
